Implementing the Xpert® MTB/RIF Diagnostic Test for Tuberculosis and Rifampicin Resistance: Outcomes and Lessons Learned in 18 Countries

• Elisa Ardizzoni ,

  * E-mail: eardizzoni@itg.be

  Affiliations Médecins Sans Frontières, Institute of Tropical Medicine, Antwerp, Belgium, Médecins Sans Frontières, Paris, France

  ⨯
• Emmanuel Fajardo,

  Affiliation Médecins Sans Frontières, Southern Africa Medical Unit, Cape Town, South Africa

  ⨯
• Peter Saranchuk,

  Affiliation Médecins Sans Frontières, Southern Africa Medical Unit, Cape Town, South Africa

  ⨯
• Martina Casenghi,

  Affiliation Médecins Sans Frontières, Geneva, Switzerland

  ⨯
• Anne-Laure Page,

  Affiliation Epicentre, Médecins Sans Frontières, Paris, France

  ⨯
• Francis Varaine,

  Affiliation Médecins Sans Frontières, Paris, France

  ⨯
• Cara S. Kosack,

  Affiliation Médecins Sans Frontières, Amsterdam, Netherlands

  ⨯
• Pamela Hepple

  Affiliation Médecins Sans Frontières, Manson Unit, London, United Kingdom

  ⨯